Loading...
•
Jun 30, 2024
CVRx Q2 2024 Earnings Report
CVRx's second quarter results were solid, driven by record U.S. Heart Failure business, with revenue increasing and strategic leadership appointments made.
Key Takeaways
CVRx reported a 24% increase in revenue to $11.8 million for Q2 2024, driven by a 29% increase in U.S. revenue. The company's gross profit was $9.9 million, with a gross margin of 84%. Net loss was $14.0 million, or $0.65 per share. The company strengthened its executive team to drive market development priorities.
Revenue increased by 24% to $11.8 million compared to the same period last year.
U.S. revenue increased by 29% to $10.7 million, driven by growth in the U.S. Heart Failure business.
Gross profit was $9.9 million with a gross margin of 84%.
Net loss was $14.0 million, or $0.65 per share.
Revenue by Segment
Revenue by Geographic Location
Forward Guidance
The Company expects to report total revenue between $12.7 million and $13.7 million for the third quarter of 2024.
Historical Earnings Impact
Analyze how earnings announcements historically affect stock price performance
Avg. Return Before/After Earnings
Loading earnings performance data...
Loading earnings reaction data...